These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1357355)

  • 1. Cladribine (2-chlorodeoxyadenosine).
    Beutler E
    Lancet; 1992 Oct; 340(8825):952-6. PubMed ID: 1357355
    [No Abstract]   [Full Text] [Related]  

  • 2. 2-Chlorodeoxyadenosine: a new nucleoside agent effective in the treatment of lymphoid malignancies.
    Saven A; Piro LD
    Leuk Lymphoma; 1993; 10 Suppl():43-9. PubMed ID: 8097654
    [No Abstract]   [Full Text] [Related]  

  • 3. [2-chlorodeoxyadenosine (2-CdA) cladribine therapy in hairy cell leukemia].
    Raanani P; Shpilberg O; Ben-Bassat I
    Harefuah; 1994 Jun; 126(11):673-6. PubMed ID: 7927005
    [No Abstract]   [Full Text] [Related]  

  • 4. 2-Chlorodeoxyadenosine, a "novel" agent in the treatment of both lymphoid and myeloid malignancies.
    Lauria F
    Haematologica; 1992; 77(6):443-5. PubMed ID: 1363233
    [No Abstract]   [Full Text] [Related]  

  • 5. 2-Chlorodeoxyadenosine: treatment of hairy cell leukemia, chronic lymphocytic leukemia, and lymphocytic lymphoma.
    Piro LD
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):28-30. PubMed ID: 7908756
    [No Abstract]   [Full Text] [Related]  

  • 6. 2-Chlorodeoxyadenosine in the treatment of hairy cell leukemia.
    Saven A; Piro LD
    Cancer Invest; 1993; 11(5):559-64. PubMed ID: 8104670
    [No Abstract]   [Full Text] [Related]  

  • 7. 2-Chlorodeoxyadenosine treatment in hairy cell leukemia.
    Anand A
    Ann Intern Med; 1994 Jan; 120(2):169. PubMed ID: 7903027
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hairy cell leukemia therapy by cladribine].
    Ogura M
    Nihon Rinsho; 2004 Jul; 62(7):1337-42. PubMed ID: 15283153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease eradication in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine.
    Carbone A; Reato G; Di Celle PF; Lauria F; Foa R
    Leukemia; 1994 Nov; 8(11):2019-20. PubMed ID: 7967746
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful pregnancy after cladribine therapy for hairy cell leukemia.
    Orlowski RZ
    Leuk Lymphoma; 2004 Jan; 45(1):187-8. PubMed ID: 15061219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complete remission in a patient with hairy cell leukemia after treatment with 2-chlorodeoxyadenosine].
    Komarnicki M; Kaźmierczak M
    Acta Haematol Pol; 1993; 24(1):77-81. PubMed ID: 8098177
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group.
    Tobinai K; Ogura M; Hotta T; Kobayashi Y; Narabayashi M; Suzuki R; Kinoshita T; Kozuru M; Uike N; Ohashi Y
    Jpn J Clin Oncol; 1997 Jun; 27(3):146-53. PubMed ID: 9255268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cladribine: from the bench to the bedside--focus on hairy cell leukemia.
    Greyz N; Saven A
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):745-57. PubMed ID: 15485311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases.
    Palomera L; Domingo JM; Sola C; Azaceta G; Calvo MT; Gutierrez M
    Haematologica; 2002 Jan; 87(1):107-8. PubMed ID: 11801472
    [No Abstract]   [Full Text] [Related]  

  • 15. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
    Yang MH; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of 2-chlorodeoxyadenosine in nodal and extra haematopoietic localizations in hairy cell leukaemia.
    Rieux C; Bastion Y; Bazin M; Dumontet C; Coiffier B; Felman P; Bryon PA
    Eur J Haematol; 1995 Aug; 55(2):133-5. PubMed ID: 7628589
    [No Abstract]   [Full Text] [Related]  

  • 17. [Failure of treatment with 2-chlorodeoxyadenosine in the course of hairy cell leukemia associated with malignant histiocytosis].
    Jullien V; Peyrade F; Taillan B; Perrin C; Sanderson F; Guzman-Granier E; Michiels JF; Dujardin P
    Rev Med Interne; 1999 Mar; 20(3):287-8. PubMed ID: 10216890
    [No Abstract]   [Full Text] [Related]  

  • 18. Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia: a multicentre trial SAKK 32/95.
    Zenhäusern R; Von Rohr A; Rufibach K; Solenthaler M; Meyer-Monard S; Gratwohl A; Hess U; Bargetzi MJ; Kovacsovic T; Leoncini L; Tobler A;
    Leuk Lymphoma; 2009 Jan; 50(1):133-6. PubMed ID: 19152171
    [No Abstract]   [Full Text] [Related]  

  • 19. 2-chlorodeoxyadenosine-associated transient acantholytic dermatosis in hairy cell leukemia patients.
    Cohen PR; Kurzrock R
    Am J Dermatopathol; 1999 Feb; 21(1):106-8. PubMed ID: 10027536
    [No Abstract]   [Full Text] [Related]  

  • 20. [2-chlorodeoxyadenosine (2-CDA)--a new antineoplastic and immunosuppressive drug].
    Robak T; Grieb P
    Acta Haematol Pol; 1992; 23(3):141-8. PubMed ID: 1362851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.